Moderna Shares Spike 11.7% on H5N1 Vaccine News
Moderna stock jumps 11.7% following potential H5N1 vaccine news amid first U.S. bird-flu fatality, boosting investor confidence.
Moderna shares surged 11.7% on news of a potential vaccine for H5N1 amid the first U.S. bird-flu fatality.